Switzerland Biotechnology & Medical Research

Newron Pharmaceuticals SpA (NWRN)

Track

Track

Newron Pharmaceuticals SpA recorded two buy transactions totaling 47,574.64 CHF over the past ninety days. These acquisitions occurred amidst a 17.2% decline in stock value. The firm's latest results financiers were published in April 2025, reflecting ongoing market volatility for this healthcare entity as shares trade near their annual lows.
Ticker: NWRN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Newron Pharmaceuticals SpA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Executive Director / Officer
Transaction date
Purchase
Price
111.09
Quantity 22,417
Value CHF702,477
Executive Director / Officer
Transaction date
Purchase
Price
101.95
Quantity 50,639
Value CHF1,685,067
Non-Executive Director
Transaction date
Sale
Price
352.41
Quantity 3,232
Value CHF4,212,523
Non-Executive Director
Transaction date
Sale
Price
17.02
Quantity 14,567
Value CHF247,984
Non-Executive Director
Transaction date
Purchase
Price
7.30
Quantity 750
Value CHF5,472
3.1
Weber, Stefan Management Board Member
Transaction date
Purchase
Price
6.90
Quantity 5,000
Value €34,503
Executive Director / Officer
Transaction date
Purchase
Price
6.47
Quantity 5,000
Value CHF32,326
Executive Director / Officer
Transaction date
Purchase
Price
8.42
Quantity 2,500
Value CHF21,058
Non-Executive Director
Transaction date
Purchase
Price
9.78
Quantity 2,502
Value CHF24,471
Non-Executive Director
Transaction date
Purchase
Price
9.76
Quantity 5,498
Value CHF53,666
Non-Executive Director
Transaction date
Purchase
Price
10.22
Quantity 2,000
Value CHF20,440
Non-Executive Director
Transaction date
Sale
Price
10.47
Quantity 10,382
Value CHF108,677
Non-Executive Director
Transaction date
Purchase
Price
5.98
Quantity 7,000
Value CHF41,860
Executive Director / Officer
Transaction date
Purchase
Price
1.45
Quantity 9,832
Value CHF14,255
Executive Director / Officer
Transaction date
Purchase
Price
2.00
Quantity 10,000
Value CHF20,000
Executive Director / Officer
Transaction date
Purchase
Price
1.86
Quantity 10,000
Value CHF18,577
Non-Executive Director
Transaction date
Purchase
Price
1.89
Quantity 5,000
Value CHF9,460
Executive Director / Officer
Transaction date
Purchase
Price
2.23
Quantity 5,000
Value CHF11,150
Executive Director / Officer
Transaction date
Purchase
Price
7.67
Quantity 2,000
Value CHF15,342
Non-Executive Director
Transaction date
Purchase
Price
7.70
Quantity 3,000
Value CHF23,100
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-12 B Purchase Executive Director / Officer
22,417
111.09
CHF702,477 		22,417 111.09 CHF702,477
2026-08-11 2026-08-11 B Purchase Executive Director / Officer
50,639
101.95
CHF1,685,067 		50,639 101.95 CHF1,685,067
2025-12-02 2025-12-02 S Sale Non-Executive Director
3,232
352.41
CHF4,212,523 		3,232 352.41 CHF4,212,523
2025-11-26 2025-11-26 S Sale Non-Executive Director
14,567
17.02
CHF247,984 		14,567 17.02 CHF247,984
2025-04-23 2025-04-23 B Purchase Non-Executive Director
750
7.30
CHF5,472 		750 7.30 CHF5,472
2025-04-07 2025-04-07 B Purchase
3.1
Weber, Stefan
Management Board Member
5,000
6.90
€34,503 		5,000 6.90 €34,503
2025-04-07 2025-04-07 B Purchase Executive Director / Officer
5,000
6.47
CHF32,326 		5,000 6.47 CHF32,326
2024-06-27 2024-06-27 B Purchase Executive Director / Officer
2,500
8.42
CHF21,058 		2,500 8.42 CHF21,058
2024-06-25 2024-06-25 B Purchase Non-Executive Director
2,502
9.78
CHF24,471 		2,502 9.78 CHF24,471
2024-06-17 2024-06-17 B Purchase Non-Executive Director
5,498
9.76
CHF53,666 		5,498 9.76 CHF53,666
2024-06-14 2024-06-14 B Purchase Non-Executive Director
2,000
10.22
CHF20,440 		2,000 10.22 CHF20,440
2024-05-16 2024-05-16 S Sale Non-Executive Director
10,382
10.47
CHF108,677 		10,382 10.47 CHF108,677
2023-03-28 2023-03-28 B Purchase Non-Executive Director
7,000
5.98
CHF41,860 		7,000 5.98 CHF41,860
2022-05-09 2022-05-09 B Purchase Executive Director / Officer
9,832
1.45
CHF14,255 		9,832 1.45 CHF14,255
2020-11-19 2020-11-19 B Purchase Executive Director / Officer
10,000
2.00
CHF20,000 		10,000 2.00 CHF20,000
2020-06-02 2020-06-02 B Purchase Executive Director / Officer
10,000
1.86
CHF18,577 		10,000 1.86 CHF18,577
2020-05-06 2020-05-06 B Purchase Non-Executive Director
5,000
1.89
CHF9,460 		5,000 1.89 CHF9,460
2020-05-04 2020-05-04 B Purchase Executive Director / Officer
5,000
2.23
CHF11,150 		5,000 2.23 CHF11,150
2018-12-03 2018-12-03 B Purchase Executive Director / Officer
2,000
7.67
CHF15,342 		2,000 7.67 CHF15,342
2018-12-03 2018-12-03 B Purchase Non-Executive Director
3,000
7.70
CHF23,100 		3,000 7.70 CHF23,100
Explore more

More insider trading research around Newron Pharmaceuticals SpA

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index